Skip to main content

Table 2 Summary of antitumor activity

From: Massive digital gene expression analysis reveals different predictive profiles for immune checkpoint inhibitor therapy between adenocarcinoma and squamous cell carcinoma of advanced lung cancer

All patients (n = 42)

Number

Percent

Type of response

PR

18

42.8

SD

11

26.2

PD

13

31.0

Objective response rate

 

42.8

Disease control rate

 

69.0

  1. PR partial response, SD stable disease, PD progressive disease
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us